Skip to main navigation Skip to search Skip to main content

Atherosclerosis Progression in the APPLE Trial Can Be Predicted in Young People With Juvenile-Onset Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature

  • APPLE trial investigators and Childhood Rheumatology Research Alliance (CARRA)

Research output: Contribution to journal › Article › peer-review

14   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Atherosclerosis Progression in the APPLE Trial Can Be Predicted in Young People With Juvenile-Onset Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology